Ciliopathy interacts with neonatal anesthesia to cause non-apoptotic caspase-mediated motor deficits.
Nemanja Sarić, Zeynep Atak, Courtni Foster Sade, Nikita Reddy, Gabrielle Bell, Christina Tolete, May T Rajtboriraks, Kazue Hashimoto-Torii, Vesna Jevtović-Todorović, Tarik F Haydar, Nobuyuki Ishibashi
bioRxiv : the preprint server for biology November 27, 2024 preprint DOI: 10.1101/2024.11.27.624302 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Animal study |
|---|---|
| Population | Neonatal ciliopathic mice |
| Intervention | Ketamine |
| Keywords | Anesthesia Developmental biology Pediatric medicine Genetics |
| Key points | Ciliopathy interacts with ketamine to induce motor impairments in neonatal mice, which are reversible through caspase inhibition. |
Abstract
Increasing evidence suggests that anesthesia may induce developmental neurotoxicity, yet the influence of genetic predispositions associated with congenital anomalies on this toxicity remains largely unknown. Children with congenital heart disease often exhibit mutations in cilia-related genes and ciliary dysfunction, requiring sedation for their catheter or surgical interventions during the neonatal period. Here we demonstrate that briefly exposing ciliopathic neonatal mice to ketamine causes motor skill impairments, which are associated with a baseline deficit in neocortical layer V neuron apical spine density and their altered dynamics during motor learning.. These neuromorphological changes were linked to augmented non-apoptotic neuronal caspase activation. Neonatal caspase suppression rescued the spine density and motor deficits, confirming the requirement for sublethal caspase signaling in appropriate spine formation and motor learning. Our findings suggest that ciliopathy interacts with ketamine to induce motor impairments, which is reversible through caspase inhibition. Furthermore, they underscore the potential for ketamine- induced sublethal caspase responses in shaping neurodevelopmental outcomes.